Logos Biosystems Highlights Automated Cell Counting Solutions for Brightfield and Fluorescence Applications
Automated cell counting options support laboratories with routine viability testing, fluorescence-based analysis and increasingly complex research workflows
SEOUL, South Korea, – SP Tech Solutions – August 12, 2026 — Logos Biosystems announced its continued focus on automated cell counting solutions designed to support laboratories choosing between brightfield and fluorescence-based analysis for different research applications.
The company’s automated cell counting technologies are intended to support workflows ranging from routine cell concentration and viability measurements to more specialized applications involving mixed cell populations, transfection studies and complex cell types.
cell counting
Brightfield cell counting uses transmitted light and image-based contrast analysis to identify cells and is commonly used with viability dyes such as trypan blue. The approach can be suitable for laboratories conducting routine counts across established cell lines, primary cells and other standard laboratory workflows.
Fluorescence-based counting provides an additional method for identifying specific cell populations through fluorescent markers. This capability can be useful when researchers need to distinguish labeled cells from other populations or evaluate applications such as transfection efficiency.
“Choosing the right cell counting method depends on the samples and applications a laboratory handles,” said Neon Jung, CEO of Logos Biosystems. “Brightfield can be an effective approach for routine counting, while fluorescence can provide additional information when researchers are working with mixed populations or more complex samples.”
The company said laboratories working with aggregated, unusually shaped or heterogeneous cells may face additional challenges when relying solely on conventional brightfield analysis. These challenges can be relevant to applications involving stem cells, organoids, immune cells and cell and gene therapy research.
Fluorescence capability can provide laboratories with additional analytical options in workflows where morphology and conventional viability staining may not adequately distinguish target cells from debris, aggregates or other particles.
Logos Biosystems said fluorescence is not necessarily required for every laboratory. Facilities primarily performing routine viability and concentration measurements may find brightfield technology sufficient for their workflows, while laboratories conducting more specialized studies may benefit from fluorescence-enabled analysis.
Factors that laboratories can consider when selecting an automated cell counting solution include:
– Sample complexity and cell population characteristics
– Cell aggregation and morphology
– Requirements for fluorescence-based identification
– Routine counting and viability workflows
– Laboratory throughput and number of users
– Potential future research applications
The company also highlighted the value of scalable automated cell counting platforms that can accommodate changing laboratory requirements. Laboratories may begin with routine brightfield counting and later require fluorescence capabilities for transfection studies, mixed-population analysis or other applications.
An upgradeable approach can allow laboratories to expand their cell analysis capabilities without replacing an entire instrument as research requirements develop.
Logos Biosystems said standardized sample preparation and consistent laboratory protocols remain important regardless of the optical technology selected. Appropriate dye selection, consistent handling procedures and optimization of cell-recognition parameters can contribute to reproducible results across users and experiments.
“Laboratories need technology that matches the work they are actually doing today while providing flexibility for future applications,” Jung said. “The goal is to help researchers select an approach that supports reliable cell analysis as their workflows evolve.”
More information about Logos Biosystems and its automated cell counting solutions is available at: https://logosbio.com/
Media Content
Suggested image: Logos Biosystems automated cell counting instrument being used in a laboratory.
Suggested caption: Logos Biosystems provides automated cell counting solutions supporting brightfield and fluorescence-based laboratory applications.
Alt text: Automated cell counting instrument used for laboratory cell analysis.
The image should be high resolution and legally authorized for distribution. It should not display private customer information, personal data, QR codes, promotional buttons or publisher logos.
About Logos Biosystems
Logos Biosystems develops automated imaging and cell analysis solutions for life sciences research laboratories. Its product portfolio supports applications involving cell counting, imaging and analysis across a range of biological research workflows.
Media Contact
Neon Jung
Logos Biosystems
Email: info@logosbio.com
Country: South Korea
Website: https://logosbio.com/